Literature DB >> 20043250

Confabulation and delusion: a common monitoring framework.

Martha Turner1, Max Coltheart.   

Abstract

Confabulations and delusions both involve the production of false claims. Although they may have different types of content, they share several characteristics. For example, they are often held with considerable conviction and are resistant to counter evidence, they may be acted upon, and they may be accompanied by a lack of concern about the false claim or its implications. Confabulations and delusions may initially arise from failures in different systems (e.g., mnemonic vs. perceptual or affective). However, their shared characteristics raise the possibility that the monitoring deficits involved might be the same, resulting in failure to reject the confabulatory or delusional ideas. In this paper we will focus on the nature of these common monitoring deficits. Critically, we argue that monitoring in confabulation and delusion involves both unconscious and conscious processes. We propose that an unconscious process is responsible for tagging suspect content which needs to be checked for veracity by a separate set of conscious evaluative processes. Failure of these monitoring processes would allow ideas which ought to be checked and rejected to instead be uncritically accepted: This would result in the production of confabulations or delusions. Importantly, inclusion of both unconscious and conscious monitoring stages allows the model to account for both "endorsement" and "explanation" delusions, and both "primary" and "secondary" confabulations. Our hope is that this model may provide a theoretical framework to guide empirical investigation of the commonalities and differences between the conditions.

Mesh:

Year:  2010        PMID: 20043250     DOI: 10.1080/13546800903441902

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  16 in total

1.  Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria".

Authors:  Mario F Mendez; Jill S Shapira
Journal:  Conscious Cogn       Date:  2011-09-29

2.  The false memory syndrome: experimental studies and comparison to confabulations.

Authors:  M F Mendez; I A Fras
Journal:  Med Hypotheses       Date:  2010-12-21       Impact factor: 1.538

Review 3.  Why did I do that? Explaining actions activated outside of awareness.

Authors:  Ana P Gantman; Marieke A Adriaanse; Peter M Gollwitzer; Gabriele Oettingen
Journal:  Psychon Bull Rev       Date:  2017-10

4.  Frontolimbic affective bias and false narratives from brain disease.

Authors:  Mario F Mendez
Journal:  Med Hypotheses       Date:  2019-04-29       Impact factor: 1.538

5.  Mnemonic monitoring in anosognosia for memory loss.

Authors:  Silvia Chapman; Stephanie Cosentino; Kay C Igwe; Ayat Abdurahman; Mitchell S V Elkind; Adam M Brickman; Rebecca Charlton; Gianna Cocchini
Journal:  Neuropsychology       Date:  2020-05-18       Impact factor: 3.295

Review 6.  Confabulations in schizophrenia.

Authors:  Mohammed K Shakeel; Nancy M Docherty
Journal:  Cogn Neuropsychiatry       Date:  2014-07-31       Impact factor: 1.871

7.  A cognitive account of belief: a tentative road map.

Authors:  Michael H Connors; Peter W Halligan
Journal:  Front Psychol       Date:  2015-02-13

8.  Dreams, reality and memory: confabulations in lucid dreamers implicate reality-monitoring dysfunction in dream consciousness.

Authors:  P R Corlett; S V Canavan; L Nahum; F Appah; P T Morgan
Journal:  Cogn Neuropsychiatry       Date:  2014-07-16       Impact factor: 1.871

9.  Using hypnosis to disrupt face processing: mirrored-self misidentification delusion and different visual media.

Authors:  Michael H Connors; Amanda J Barnier; Max Coltheart; Robyn Langdon; Rochelle E Cox; Davide Rivolta; Peter W Halligan
Journal:  Front Hum Neurosci       Date:  2014-06-18       Impact factor: 3.169

10.  Psychosis, agnosia, and confabulation: an alternative two-factor account.

Authors:  Mark A Turner
Journal:  Cogn Neuropsychiatry       Date:  2013-07-03       Impact factor: 1.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.